To hear about similar clinical trials, please enter your email below
Trial Title:
Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II)
NCT ID:
NCT06007794
Condition:
Cancer
Post-cancer
Hematology
Conditions: Keywords:
post-cancer
sarcopenia
medical evaluation
muscle
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Prevention
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
JUMP group
Description:
patients will have a femoral ultrasound and blood tubes in addition to the blood sample
taken as part of the treatment
Arm group label:
JUMP group
Summary:
Therapeutic advances in oncology have transformed the prognosis of cancer patients,
placing a significant number of them either in a context of recovery or in prolonged
remission close to a chronic disease. Thus, the reconquest of a life after cancer becomes
possible but raises many challenges for the patient, his entourage, the medical
profession and our society. One of the major challenges is the detection and management
of treatment side effects for all patients. In addition to the standard organic
assessment (glycaemia, creatinine, liver test, blood count), we are mainly interested in
muscle deconditioning and cognitive impairment, which are particularly disturbed in these
populations. After the evaluation day, patients are referred to the most appropriate
structures (Adapted physical activity, sports for health, and rehabilitation at Henry
Gabriel Hospital).
JUMP research is part of axis 2 of the 2021-2030 cancer plan: "Limiting sequelae and
improving quality of life", through sheets 1 (research) / 6 (access and quality) / 7
(prevention). This leads to the concrete implementation on the territory of adapted care
channels in the city: medical structure, physiotherapy, Adapted Physical Activity (APA)
structures, associative structures; which makes it possible to develop and strengthen the
city-hospital link. Finally, it allows the patient to take ownership and get involved in
the project, allowing in the future to make them truly active in they care and to advise
and motivate their peers.
This non-interventional research is classified as "research involving human subjects",
class 3 .
The objective of this research is to evaluate the impact of cancer on the musculoskeletal
system and to test ultrasound as a clinical examination for the detection of sarcopenia
in this population.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age : 18 to 74 years
- localization of the primitive: breast, lung, melanoma, testicle, bladder, kidney,
ovary, colon and pancreas, hemopathy
- patient who benefited from the post-cancer assessment day
Exclusion Criteria:
- Active cancer (relapse or new cancer)
- Pregnant or breastfeeding women
- Major cognitive impairment making comprehension and exercise difficult
- Amputation of both lower limbs (for ultrasound)
- Difficulty understanding oral and written French
- Adults under legal protection (guardianship, curatorship or safeguard of justice)
Gender:
All
Minimum age:
18 Years
Maximum age:
74 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Hôpital Lyon Sud, rhumatologie
Address:
City:
Pierre-Bénite
Zip:
69495
Country:
France
Contact:
Last name:
Cyrille CONFAVREUX, Md,PhD
Phone:
+334 78 86 12 31
Email:
Cyrille.confavreux@chu-lyon.fr
Start date:
October 1, 2024
Completion date:
December 1, 2028
Lead sponsor:
Agency:
Hospices Civils de Lyon
Agency class:
Other
Source:
Hospices Civils de Lyon
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06007794
